Literature DB >> 2887515

Serological response to the P fimbriae of uropathogenic Escherichia coli in pyelonephritis.

J M de Ree, J F van den Bosch.   

Abstract

Uropathogenic Escherichia coli strains isolated from four patients with pyelonephritis were characterized by their O:K serotype, hemolysin production, mannose-resistant hemagglutination, and the serotype of the P fimbriae. These P fimbriae were serotyped with specific monoclonal antibodies. Serum samples from the patients were analyzed for the presence of specific antibodies to the P fimbriae. In all cases antifimbrial antibodies were found, strongly suggesting that these P fimbriae are expressed in vivo. However, the antibodies in the patient sera were not able to inhibit the mannose-resistant hemagglutination. This finding suggests that these antibodies react with the fimbrial components and not with the minor components which are responsible for adhesion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887515      PMCID: PMC260679          DOI: 10.1128/iai.55.9.2204-2207.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli.

Authors:  V Väisänen; T K Korhonen; M Jokinen; C G Gahmberg; C Ehnholm
Journal:  Lancet       Date:  1982-05-22       Impact factor: 79.321

2.  New Method for isolation of immunologically pure pili from Escherichia coli.

Authors:  T K Korhonen; E L Nurmiaho; H Ranta; C S Edén
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

3.  Virulence of urinary and faecal Escherichia coli in relation to serotype, haemolysis and haemagglutination.

Authors:  J F van den Bosch; P Postma; P A Koopman; J de Graaff; D M MacLaren; D G van Brenk; P A Guinée
Journal:  J Hyg (Lond)       Date:  1982-06

4.  Lack of adherence to epithelial cells by freshly isolated urinary pathogens.

Authors:  M J Harber; S Chick; R Mackenzie; A W Asscher
Journal:  Lancet       Date:  1982-03-13       Impact factor: 79.321

5.  Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate.

Authors:  R A Hull; R E Gill; P Hsu; B H Minshew; S Falkow
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

Review 6.  Adhesion of Escherichia coli in urinary tract infection.

Authors:  C S Edén; L Hagberg; L A Hanson; T Korhonen; H Leffler; S Olling
Journal:  Ciba Found Symp       Date:  1981

7.  Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis.

Authors:  V Väisänen; J Elo; L G Tallgren; A Siitonen; P H Mäkelä; C Svanborg-Edén; G Källenius; S B Svenson; H Hultberg; T Korhonen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

8.  Occurrence of P-fimbriated Escherichia coli in urinary tract infections.

Authors:  G Källenius; R Möllby; S B Svenson; I Helin; H Hultberg; B Cedergren; J Winberg
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

9.  Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections.

Authors:  L Hagberg; U Jodal; T K Korhonen; G Lidin-Janson; U Lindberg; C Svanborg Edén
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

10.  Mannose-sensitive and mannose-resistant adherence to human uroepithelial cells and urinary virulence of Escherichia coli.

Authors:  J F van der Bosch; U Verboom-Sohmer; P Postma; J de Graaff; D M MacLaren
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

View more
  13 in total

1.  Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin.

Authors:  A E Wold; J Mestecky; M Tomana; A Kobata; H Ohbayashi; T Endo; C S Edén
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  DNA sequences of three papA genes from uropathogenic Escherichia coli strains: evidence of structural and serological conservation.

Authors:  K Denich; L B Blyn; A Craiu; B A Braaten; J Hardy; D A Low; P D O'Hanley
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 3.  Applications from bacterial adhesion and biofilm studies in relation to urogenital tissues and biomaterials: a review.

Authors:  G Reid
Journal:  J Ind Microbiol       Date:  1994-03

4.  Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media.

Authors:  D L Gally; J A Bogan; B I Eisenstein; I C Blomfield
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

5.  Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12.

Authors:  I C Blomfield; P J Calie; K J Eberhardt; M S McClain; B I Eisenstein
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

6.  Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.

Authors:  J R Johnson; A L Stell; F Scheutz; T T O'Bryan; T A Russo; U B Carlino; C Fasching; J Kavle; L Van Dijk; W Gaastra
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 7.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

8.  The PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activity.

Authors:  R Tewari; T Ikeda; R Malaviya; J I MacGregor; J R Little; S J Hultgren; S N Abraham
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 9.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

10.  Characterization of P fimbriae on O1, O7, O75, rough, and nontypable strains of Escherichia coli.

Authors:  A Pere; R K Selander; T K Korhonen
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.